Symptom severity and attitudes toward medication: Impacts on adherence in outpatients with schizophrenia

Schizophrenia Research

Volumn 134, Issue 2-3, 2012, Pages 226-231

  Yang, Jaewon ^a,b   Ko, Young Hoon ^a,b   Paik, Jong Woo ^d   Lee, Moon Soo ^b,c   Han, Changsu ^a,b   Joe, Sook Haeng ^b,c   Jung, In Kwa ^b,c   Jung, Hyun Gang ^b,c   Kim, Seung Hyun ^b,c  

^a Korea University College of Medicine   (South Korea)

^b Korea University   (South Korea)

^c Korea University College of Medicine   (South Korea)

^d Kyung Hee University Hospital   (South Korea)

Author keywords

Adherence; Attitude; Medication Event Monitoring System; Schizophrenia; Symptom

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; BEHAVIOR; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL RATING SCALE; COGNITION; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ATTITUDE INVENTORY; EXCITEMENT; FEMALE; HUMAN; IMPULSE CONTROL; MAJOR CLINICAL STUDY; MALE; MEDICATION EVENT MONITORING SYSTEM; MONITORING; MULTIDIMENSIONAL SCALE OF PERCEIVED SOCIAL SUPPORT; OUTPATIENT; PATIENT ATTITUDE; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PREOCCUPATION; PRIORITY JOURNAL; RATING SCALE; REMINDER SYSTEM; SCHIZOPHRENIA; SCORING SYSTEM; SELF REPORT; UNSPECIFIED SIDE EFFECT;

ADULT; ANTIPSYCHOTIC AGENTS; ATTITUDE TO HEALTH; DRUG MONITORING; FEMALE; HUMANS; MALE; MEDICATION ADHERENCE; MIDDLE AGED; OUTPATIENTS; PERSONALITY INVENTORY; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84856304513     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2011.11.008     Document Type: Article

References (35)

1. Ascher-Svanum H., Zhu B., Faries D., Lacro J.P., Dolder C.R. A prospective study of risk factors for nonadherence with antipsychotic medication in the treatment of schizophrenia. J. Clin. Psychiatry 2006, 67(7):1114-1123.
2. Barbui C., Kikkert M., Mazzi M.A., Becker T., Bindman J., Schene A., Nose M., Helm H., Thornicroft G., Tansella M. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence. Psychopathology 2009, 42(5):311-317.
3. Beck E.M., Cavelti M., Wirtz M., Kossowsky J., Vauth R. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach. Psychiatry Res. 2011, 187(1-2):55-61.
4. Bies R.R., Gastonguay M.R., Coley K.C., Kroboth P.D., Pollock B.G. Evaluating the consistency of pharmacotherapy exposure by use of state-of-the-art techniques. Am. J. Geriatr. Psychiatry 2002, 10(6):696-705.
5. Byerly M., Fisher R., Whatley K., Holland R., Varghese F., Carmody T., Magouirk B., Rush A.J. A comparison of electronic monitoring vs. clinician rating of antipsychotic adherence in outpatients with schizophrenia. Psychiatry Res. 2005, 133(2-3):129-133.
6. Byerly M.J., Thompson A., Carmody T., Bugno R., Erwin T., Kashner M., Rush A.J. Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia. Psychiatr. Serv. 2007, 58(6):844-847.
7. Deegan P.E., Drake R.E. Shared decision making and medication management in the recovery process. Psychiatr. Serv. 2006, 57(11):1636-1639.
8. Diaz E., Levine H.B., Sullivan M.C., Sernyak M.J., Hawkins K.A., Cramer J.A., Woods S.W. Use of the Medication Event Monitoring System to estimate medication compliance in patients with schizophrenia. J. Psychiatry Neurosci. 2001, 26(4):325-329.
9. Eker D., Arkar H. Perceived social support: psychometric properties of the MSPSS in normal and pathological groups in a developing country. Soc. Psychiatry Psychiatr. Epidemiol. 1995, 30(3):121-126.
10. Gaebel W., Riesbeck M., von Wilmsdorff M., Burns T., Derks E.M., Kahn R.S., Rossler W., Fleischhacker W.W. Drug attitude as predictor for effectiveness in first-episode schizophrenia: results of an open randomized trial (EUFEST). Eur. Neuropsychopharmacol. 2010, 20(5):310-316.
11. Guy W. ECDEU assessment manual for psychopharmacology. US Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs, Rockville 1976.
12. Haynes R., Taylor D., Sackett D. Compliance in Health Care 1979, Johns Hopkins University Press, Baltimore.
13. Hogan T.P., Awad A.G., Eastwood M.R. A self-report scale predictive of drug compliance in schizophrenia: reliability and discriminative validity. Psychol. Med. 1983, 13:177-183.
14. Jung H.Y., Joo Y.H., Shin H.K., Cung E.K., Kang U.G., Roh M.S., Kim Y.S. A validation study of Korean-vesion of Liverpool University neuroleptic side effect rating scale (LUNSERS). J. Korean Neuropsychiatr. Assoc. 2002, 41(1):138-145.
15. Kampman O., Laippala P., Vaananen J., Koivisto E., Kiviniemi P., Kilkku N., Lehtinen K. Indicators of medication compliance in first-episode psychosis. Psychiatry Res. 2002, 110(1):39-48.
16. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
17. Kim J.H., Yim S.J., Yoon H.J. Assessing the reliability and validity of the Korean version of the revised insight scale for psychosis (KISP). Schizophr. Clinics 2004, 7(1):15-21.
18. Kim Y.K., Won S.D., Lee K.M., Choi H.S., Jang H.S., Lee B.H. A study on the reliability and validity of the Korean version of the calgary depression scale for schizophrenia. J. Korean Neuropsychiatr. Assoc. 2005, 44(4):446-466.
19. Kim S.W., Yoon J.S., Choi S.K. Survey of medication adherence in patients with schizophrenia-Korean ADHES data. Hum. Psychopharmacol. 2006, 21(8):533-537.
20. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J. Clin. Psychiatry 2002, 63:892-909.
21. Lin L.I. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989, 45(1):255-268.
22. Lindenmayer J.P., Liu-Seifert H., Kulkarni P.M., Kinon B.J., Stauffer V., Edwards S.E., Chen L., Adams D.H., Ascher-Svanum H., Buckley P.F., Citrome L., Volavka J. Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response. J. Clin. Psychiatry 2009, 70(7):990-996.
23. Naber D. A self-rating to measure subjective effects of neuroleptic drugs, relationships to objective psychopathology, quality of life, compliance and other clinical variables. Int. Clin. Psychopharmacol. 1995, 10(Suppl 3):133-138.
24. Novick D., Haro J.M., Suarez D., Perez V., Dittmann R.W., Haddad P.M. Predictors and clinical consequences of non-adherence with antipsychotic medication in the outpatient treatment of schizophrenia. Psychiatry Res. 2010, 176(2-3):109-113.
25. Perkins D.O. Predictors of noncompliance in patients with schizophrenia. J. Clin. Psychiatry 2002, 63:1121-1128.
26. Perkins D.O., Johnson J.L., Hamer R.M., Zipursky R.B., Keefe R.S., Centorrhino F., Green A.I., Glick I.B., Kahn R.S., Sharma T., Tohen M., McEvoy J.P., Weiden P.J., Lieberman J.A. Predictors of antipsychotic medication adherence in patients recovering from a first psychotic episode. Schizophr. Res. 2006, 83(1):53-63.
27. Perkins D.O., Gu H., Weiden P.J., McEvoy J.P., Hamer R.M., Lieberman J.A. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study. J. Clin. Psychiatry 2008, 69(1):106-113.
28. Remington G., Kwon J., Collins A., Laporte D., Mann S., Christensen B. The use of electronic monitoring (MEMS) to evaluate antipsychotic compliance in outpatients with schizophrenia. Schizophr. Res. 2007, 90(1-3):229-237.
29. Ruscher S.M., de Wit R., Mazmanian D. Psychiatric patients' attitudes about medication and factors affecting noncompliance. Psychiatr. Serv. 1997, 48(1):82-85.
30. Sawant N.S., Jethwani K.S. Understanding family functioning and social support in unremitting schizophrenia: a study in India. Indian J Psychiatry 2010, 52(2):145-149.
31. Velligan D.I., Weiden P.J., Sajatovic M., Scott J., Carpenter D., Ross R., Docherty J.P. The expert consensus guideline series: adherence problems in patients with serious and persistent mental illness. J. Clin. Psychiatry 2009, 70(Suppl 4):1-46.
32. Voruganti L.N., Awad A.G. Personal evaluation of transitions in treatment (PETiT): a scale to measure subjective aspects of antipsychotic drug therapy in schizophrenia. Schizophr. Res. 2002, 56:37-46.
33. Yamada K., Watanabe K., Nemoto N., Fujita H., Chikaraishi C., Yamauchi K., Yagi G., Asai M., Kanba S. Prediction of medication noncompliance in outpatients with schizophrenia: 2-year follow-up study. Psychiatry Res. 2006, 141(1):61-69.
34. Yi J.S., Ahn Y.M., Shin H.K., An S.K., Joo Y.H., Kim S.H., Yoon D.J., Jho K.H., Koo Y.J. Reliability and validity of the Korean version of the positive and negative syndrome scale. J. Korean Neuropsychaitr. Assoc. 2001, 40(6):1090-1105.
35. Yoon B.H., Bahk W.M., Lee K.U., Hong C.H., Ahn J.K., Kim M.K. Psychometric properties of Korean version of drug attitude inventory (KDAI-10). Korean J. Psychopharmacol. 2005, 16(6):480-487.